Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancer

Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone, according to a Radiat... Share it

Read the Full Story at Physorg